2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer
about
Cutaneous metastasis of medullary carcinoma thyroid masquerading as subcutaneous nodules anterior chest and mandibular region.Diagnosis, treatment, and follow-up of medullary thyroid carcinoma: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism.RET mutation p.S891A in a Chinese family with familial medullary thyroid carcinoma and associated cutaneous amyloidosis binding OSMR variant p.G513D.Distribution of RET Mutations and Evaluation of Treatment Approaches in Hereditary Medullary Thyroid Carcinoma in Turkey.Disease-modifying polymorphisms and C609Y mutation of RET associated with high penetrance of phaeochromocytoma and low rate of MTC in MEN2A.Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease--a consensus statement of the European Society of Endocrine Surgeons (ESES).Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?Cabozantinib (XL184) for the treatment of locally advanced or metastatic progressive medullary thyroid cancer.Calcitonin receptor expression in medullary thyroid carcinomaSerum calcitonin reference values for calcium stimulation tests by electrochemiluminescence immunoassay in Japanese men with non-medullary thyroid carcinoma.The results of molecular genetic testing for RET proto-oncogene mutations in patients with medullary thyroid carcinoma in a referral center after the two decade period.Genetic diagnosis of a Chinese multiple endocrine neoplasia type 2A family through whole genome sequencing.New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outcome of cases with double RET mutations.The RET C611Y mutation causes MEN 2A and associated cutaneousMedullary Thyroid Carcinoma With Exon 2 p.L56M RET Variant: Clinical Particular Features in Two PatientsCalcitonin measurement in fine-needle aspirate washout fluid by electrochemiluminescence immunoassay for thyroid tumors
P2860
Q34575327-9F8FF9EB-B624-43E1-8EEC-615B4C55411AQ35396089-6605B032-601F-434D-AED5-11890896EBCEQ36545363-7359054C-BC7A-4AB3-9D1D-A327228361FAQ36722002-F522A48C-9795-42CD-942C-8E50C35E5472Q37490849-37041FB2-731A-4DE7-8625-A0DF7F4FD979Q38168128-12FAA2E7-6A59-4950-84B5-73AC155E4E22Q39091785-80B02E77-A807-47D9-9809-B80468F51471Q39374983-BC22F2E9-18B4-457E-8A26-F497FB162653Q41722987-6645DA49-940D-4107-B730-DCFC857042C1Q42513839-8D73BFB9-EE5A-467E-B43B-1B1721A1542FQ47135303-1A928BCB-FE8C-4310-9013-064EF4E5B8E2Q48786445-ED211975-BB87-4450-B459-4ACD360E6AA1Q52984965-84422EDA-C198-494E-8954-C3A929D2AE57Q57300636-80445B06-9EB6-45EE-AF6E-CD00097D5A5BQ57652811-4010ADE4-9837-448C-B66B-ABC521CCFCC0Q59132399-70861A3A-1B97-4755-A930-E9A5AA7F0582
P2860
2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 December 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
2012 European thyroid associat ...... es in medullary thyroid cancer
@en
2012 European thyroid associat ...... s in medullary thyroid cancer.
@nl
type
label
2012 European thyroid associat ...... es in medullary thyroid cancer
@en
2012 European thyroid associat ...... s in medullary thyroid cancer.
@nl
prefLabel
2012 European thyroid associat ...... es in medullary thyroid cancer
@en
2012 European thyroid associat ...... s in medullary thyroid cancer.
@nl
P2093
P2860
P356
P1476
2012 European thyroid associat ...... es in medullary thyroid cancer
@en
P2093
B Conte-Devolx
G R Williams
K Frank-Raue
M Alevizaki
P2860
P304
P356
10.1159/000346174
P577
2012-12-19T00:00:00Z